Synthetic lethal compound combinations reveal a fundamental connection between wall teichoic acid and peptidoglycan

Jennifer Campbell1, Atul K Singh, John P Santa Maria

  • 1Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts 02115, United States.

ACS Chemical Biology
|October 22, 2010
PubMed

Insights

Blocking wall teichoic acid (WTA) synthesis in methicillin-resistant Staphylococcus aureus (MRSA) with TarO inhibitors resensitizes MRSA to beta-lactams. This synthetic lethality offers a novel strategy against antibiotic-resistant infections.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Drug Discovery

Background:

  • Methicillin resistance in Staphylococcus aureus (MRSA) is primarily mediated by the mecA gene, encoding penicillin-binding protein 2A (PBP2A).
  • While PBP2A confers resistance to beta-lactam antibiotics, its expression alone is insufficient for full resistance.
  • Effective strategies to combat MRSA are urgently needed due to rising antibiotic resistance.

Purpose of the Study:

  • To investigate the role of wall teichoic acids (WTAs) in MRSA beta-lactam resistance.
  • To explore the potential of inhibiting WTA synthesis as a therapeutic approach against MRSA.
  • To identify synergistic drug combinations for overcoming antibiotic resistance.

Main Methods:

  • Inhibition of TarO, the first enzyme in the WTA synthesis pathway.
  • Treatment of MRSA strains with TarO inhibitors alone and in combination with beta-lactam antibiotics.
  • Assessment of beta-lactam susceptibility.
  • Transmission electron microscopy to analyze cell wall structure and division.

Main Results:

  • Inhibiting TarO sensitized MRSA strains to beta-lactams, even with PBP2A expression.
  • A synergistic effect was observed between TarO inhibitors and beta-lactams.
  • Blocking WTA synthesis led to significant defects in S. aureus cell septation and separation.
  • These findings suggest a functional link between WTA synthesis and peptidoglycan assembly.

Conclusions:

  • Wall teichoic acids play a critical role in Staphylococcus aureus cell division.
  • The combination of TarO inhibitors and beta-lactams demonstrates synthetic lethality against MRSA.
  • This approach holds therapeutic potential for treating antibiotic-resistant bacterial infections.

Related Concept Videos

Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Peptidoglycan Synthesis01:28

Peptidoglycan Synthesis

Structure of PeptidoglycanPeptidoglycan is a vital structural component of the bacterial cell wall, providing mechanical strength and shape to the cell. It consists of repeating units of two sugars—N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)—linked by β-1,4 glycosidic bonds. These sugar chains are cross-linked by short peptide chains, forming a mesh-like polymer that surrounds the bacterial plasma membrane.Cytoplasmic Phase – Precursor SynthesisPeptidoglycan biosynthesis begins in...
Bacterial Cell Wall01:22

Bacterial Cell Wall

The bacterial cell wall is an essential structural component that encases the plasma membrane, preserving cellular integrity, determining shape, and protecting against osmotic stress. This rigid yet flexible structure primarily comprises peptidoglycan, a polymer that forms a mesh-like matrix conferring mechanical strength and flexibility.Peptidoglycan Composition and StructurePeptidoglycan, the core of the bacterial cell wall, comprises alternating units of N-acetylglucosamine (NAG) and...
Archaeal Cell Wall01:29

Archaeal Cell Wall

Archaeal cell walls are structurally and compositionally distinct from their bacterial counterparts, lacking the characteristic peptidoglycan layer found in most bacteria. Instead, archaeal cell walls exhibit remarkable diversity, utilizing materials such as pseudomurein, polysaccharides, and proteins to construct their protective outer layers. This structural flexibility is closely tied to archaea's ecological adaptability.S-Layers: The Common Archaeal Cell WallThe S-layer is the most...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Bacterial Toxins01:12

Bacterial Toxins

Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...